What’s the difference between legal and illegal promotion of off-label uses?
Many drug and device companies don’t know the right answer.
Miscues with off-label promotion are nearly always the result of weak (or nonexistent) training that assures it’s only a matter of time until a promising promotion strategy turns in to a legal nightmare – a nightmare that can result in fines, criminal penalties and liability lawsuits involving millions, even billions of dollars.
Here’s what you need to know NOW to avoid a call from the FDA’s Office of Criminal Investigations about an off-label violation.
This report is the clearest and most practical training available today for avoiding problems with off-label promotion.
Step-by-step, in plain English, it tells what drug- and devicemakers must do to navigate between legal and illegal dissemination of off-label use information … and minimize product liability concerns.
Buy now to arm your marketing team, sales reps, training staff and others with the knowledge they need to promote your products — without the risk of off-label violations. Specifically, with this guide, you’ll learn:
Buy Now!
Offered by FDAnews in print or PDF format for $377.
Satisfaction Guaranteed
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your publication? Return the hard copy within 30
days (in resalable condition), and we will refund 100 percent of your purchase price (less shipping/handling). For the PDF version, you must notify FDAnews within
24 hours of receipt of purchase to receive a refund.
|
Interested in purchasing more than one print copy? Significant volume discounts are available for ordering three or more copies of the same book. You must order them at the same time and provide a single payment to take advantage of the discount. Order below by clicking submit and then change your quantity in the shopping cart. The discount will be calculated automatically.
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally with any questions.
Interested in Electronic Multi-user Access? Phone: +1 (703) 538-7600 or toll free (888) 838-5578 Email: customerservice@fdanews.com |